SG11201604787SA - Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof - Google Patents
Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereofInfo
- Publication number
- SG11201604787SA SG11201604787SA SG11201604787SA SG11201604787SA SG11201604787SA SG 11201604787S A SG11201604787S A SG 11201604787SA SG 11201604787S A SG11201604787S A SG 11201604787SA SG 11201604787S A SG11201604787S A SG 11201604787SA SG 11201604787S A SG11201604787S A SG 11201604787SA
- Authority
- SG
- Singapore
- Prior art keywords
- omega
- alpha
- preparation
- methods
- solid forms
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/557—Eicosanoids, e.g. leukotrienes or prostaglandins
- A61K31/559—Eicosanoids, e.g. leukotrienes or prostaglandins having heterocyclic rings containing hetero atoms other than oxygen
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/38—Heterocyclic compounds having sulfur as a ring hetero atom
- A61K31/381—Heterocyclic compounds having sulfur as a ring hetero atom having five-membered rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0048—Eye, e.g. artificial tears
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
- A61P27/06—Antiglaucoma agents or miotics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/28—Halogen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Ophthalmology & Optometry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361915575P | 2013-12-13 | 2013-12-13 | |
| PCT/US2014/070156 WO2015089475A1 (en) | 2013-12-13 | 2014-12-12 | Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201604787SA true SG11201604787SA (en) | 2016-07-28 |
Family
ID=52282957
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201709702UA SG10201709702UA (en) | 2013-12-13 | 2014-12-12 | Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof |
| SG11201604787SA SG11201604787SA (en) | 2013-12-13 | 2014-12-12 | Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG10201709702UA SG10201709702UA (en) | 2013-12-13 | 2014-12-12 | Solid forms of an alpha, omega di-substituted dihydroxy cyclopentyl compound and methods for the preparation and use thereof |
Country Status (16)
| Country | Link |
|---|---|
| US (2) | US9353079B2 (es) |
| EP (1) | EP3080096A1 (es) |
| JP (2) | JP2016539994A (es) |
| KR (1) | KR20160097310A (es) |
| CN (1) | CN105814033B (es) |
| AU (1) | AU2014361794B2 (es) |
| BR (1) | BR112016013594A8 (es) |
| CA (1) | CA2933556A1 (es) |
| CL (2) | CL2016001448A1 (es) |
| IL (2) | IL245917B (es) |
| MX (1) | MX2016007717A (es) |
| RU (1) | RU2730520C2 (es) |
| SA (1) | SA516371307B1 (es) |
| SG (2) | SG10201709702UA (es) |
| UA (1) | UA121108C2 (es) |
| WO (1) | WO2015089475A1 (es) |
Families Citing this family (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US10206813B2 (en) | 2009-05-18 | 2019-02-19 | Dose Medical Corporation | Implants with controlled drug delivery features and methods of using same |
| WO2019023211A1 (en) | 2017-07-25 | 2019-01-31 | Allergan, Inc. | SOLID COMPLEX COMPRISING (Z) -7 - ((1R, 2R, 3R, 5S) -2 - ((S, E) -5- (2,5-DICHLOROTHIOPHEN-3-YL) -3-HYDROXYPENT-1 EN-1-YL) -3,5-DIHYDROXYCYCLOPENTYL) HEPT-5-ENAMIDE, PREPARATION THEREOF AND USES THEREOF |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| NO143741C (no) * | 1972-07-13 | 1981-04-08 | Pfizer | Analogifremgangsmaate for fremstilling av fysiologisk aktive prostaglandinforbindelser av e- og f-serien |
| US5296504A (en) * | 1988-09-06 | 1994-03-22 | Kabi Pharmacia | Prostaglandin derivatives for the treatment of glaucoma or ocular hypertension |
| US6602900B2 (en) | 1992-09-21 | 2003-08-05 | Allergan, Inc. | Cyclopentane heptan(ENE)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US5834498A (en) * | 1992-09-21 | 1998-11-10 | Allergan | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| US6124344A (en) * | 1993-12-28 | 2000-09-26 | Allergan Sales, Inc. | Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents |
| ES2159734T3 (es) * | 1995-05-18 | 2001-10-16 | Allergan Sales Inc | Derivados 2-heteroarilalquenilicos del acido ciclopentano-heptan(en)oico como agentes terapeuticos para el tratamiento de la hipertension ocular. |
-
2014
- 2014-12-12 US US14/569,210 patent/US9353079B2/en active Active
- 2014-12-12 JP JP2016538513A patent/JP2016539994A/ja active Pending
- 2014-12-12 EP EP14824284.5A patent/EP3080096A1/en not_active Withdrawn
- 2014-12-12 RU RU2016123446A patent/RU2730520C2/ru active
- 2014-12-12 CN CN201480067663.3A patent/CN105814033B/zh not_active Expired - Fee Related
- 2014-12-12 UA UAA201606260A patent/UA121108C2/uk unknown
- 2014-12-12 SG SG10201709702UA patent/SG10201709702UA/en unknown
- 2014-12-12 MX MX2016007717A patent/MX2016007717A/es unknown
- 2014-12-12 AU AU2014361794A patent/AU2014361794B2/en not_active Ceased
- 2014-12-12 BR BR112016013594A patent/BR112016013594A8/pt not_active IP Right Cessation
- 2014-12-12 SG SG11201604787SA patent/SG11201604787SA/en unknown
- 2014-12-12 KR KR1020167018489A patent/KR20160097310A/ko not_active Application Discontinuation
- 2014-12-12 WO PCT/US2014/070156 patent/WO2015089475A1/en active Application Filing
- 2014-12-12 CA CA2933556A patent/CA2933556A1/en not_active Abandoned
-
2016
- 2016-05-05 US US15/147,700 patent/US20170087163A1/en not_active Abandoned
- 2016-05-30 IL IL245917A patent/IL245917B/en active IP Right Grant
- 2016-06-10 CL CL2016001448A patent/CL2016001448A1/es unknown
- 2016-06-13 SA SA516371307A patent/SA516371307B1/ar unknown
-
2019
- 2019-02-22 CL CL2019000471A patent/CL2019000471A1/es unknown
- 2019-12-23 JP JP2019231685A patent/JP2020073513A/ja active Pending
-
2021
- 2021-06-08 IL IL283810A patent/IL283810A/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2020073513A (ja) | 2020-05-14 |
| AU2014361794B2 (en) | 2019-04-04 |
| CN105814033B (zh) | 2019-10-25 |
| CL2019000471A1 (es) | 2019-07-12 |
| UA121108C2 (uk) | 2020-04-10 |
| BR112016013594A2 (es) | 2017-08-08 |
| CL2016001448A1 (es) | 2017-03-03 |
| US20170087163A1 (en) | 2017-03-30 |
| MX2016007717A (es) | 2016-09-09 |
| IL283810A (en) | 2021-07-29 |
| BR112016013594A8 (pt) | 2020-05-19 |
| US20150166504A1 (en) | 2015-06-18 |
| AU2014361794A1 (en) | 2016-06-16 |
| CA2933556A1 (en) | 2015-06-18 |
| SG10201709702UA (en) | 2018-01-30 |
| WO2015089475A1 (en) | 2015-06-18 |
| US9353079B2 (en) | 2016-05-31 |
| EP3080096A1 (en) | 2016-10-19 |
| IL245917A0 (en) | 2016-08-02 |
| RU2730520C2 (ru) | 2020-08-24 |
| CN105814033A (zh) | 2016-07-27 |
| KR20160097310A (ko) | 2016-08-17 |
| JP2016539994A (ja) | 2016-12-22 |
| IL245917B (en) | 2021-06-30 |
| SA516371307B1 (ar) | 2018-10-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL261602A (en) | CD40 antibodies with increased agonistic activity | |
| EP2951158A4 (en) | PROCESS FOR THE PREPARATION OF IVACAFTOR AND SOLVATES THEREOF | |
| EP2970418A4 (en) | EZH2 PEPTIDE STABILIZED | |
| HRP20181122T1 (hr) | Postupak za pripremu jopamidola | |
| PT3071247T (pt) | Dispositivo para a construção de pele | |
| HUE040294T2 (hu) | Katalizátor foszgén elõállításához és eljárás foszgén elõállítására a katalizátor alkalmazásával | |
| IL245474A0 (en) | Process for the preparation of 5-fluoro-1h-pyrazoles | |
| IL245476A0 (en) | Process for preparing 5-fluoro-1h-pyrazoles | |
| HK1202533A1 (en) | Intermediates of ticagrelor and the preparation methods and for the preparation of ticagrelor | |
| HK1220456A1 (zh) | -乙酰嗎啡類似物，和其合成方法和用途 | |
| IL283810A (en) | Solid forms of the compound alpha, omega-di-converted dihydroxy cyclopentyl and methods for their preparation and use | |
| EP3065726A4 (en) | Creatine analogs and the use thereof | |
| ZA201603457B (en) | Novel method for the synthesis of agomelatine | |
| IL229326A (en) | Process for making n-iodine-affluent | |
| ZA201504080B (en) | Combination medicament comprising phenylephrine and paracetamol | |
| GB2510444B (en) | Combination of phenylephrine and paracetamol | |
| GB201323123D0 (en) | Method for the preparation of biopolymers | |
| HK1203297A2 (en) | Mouse sticking structure with caution function | |
| EP2983660A4 (en) | MONO-ETHERS OF ISOHEXIDES AND METHOD FOR THE PRODUCTION THEREOF | |
| IL246188A0 (en) | A process for the preparation of tiacomycin | |
| TH1401004311B (th) | วิธีการสำหรับการผลิตวัตถุขึ้นรูปด้วยโฟมและวัตถุขึ้นรูปด้วยโฟม | |
| CO6990721A2 (es) | Proceso para la preparación de análogos de magnolol | |
| TWM475359U (en) | Improved structure of album |